Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

A Method for Restoring BMP-Receptor Signaling in a Cell

11.09.2012
<strong>Background</strong><br>

Defects in BMP signaling can cause different diseases, e.g. interruption of the BMP/cGKI (cGMP-dependent protein kinase I) pathway due to a mutation in the BMP receptor II (BRII) protein causes e.g. pulmonary artery hypertension.<br><br> <strong>Technology</strong><br>

We offer assays for the screening of compounds that are involved in the BMP-receptor signaling and are suitable for restoring BMP-Receptor signaling in a cell.<br><br> The assays uses the BMP-receptor for the screening for compounds with a high cGMP dependent protein kinase 1 activity (cGKI) or uses cGKI for screening for receptors that are associated with it. The novel cGKI-based pharmaceuticals can be used to treat a cell, tissue or an organism with a disease or a condition that is associated with impeded or interrupted BMPreceptor<br><br> signaling, insofar as the activity of cGKI is increased in the cell, tissue or organ to be treated.<br><br> Those diseases can be pulmonary artery hypertension, fibrosis, cancer, bone disease, including brachydaktyly and fractures or neurodegenerative diseases.<br><br> <p><strong>Benefits</strong> <ul> <li>Method offers an additive for restoring or enhancing BMP receptor signaling</li> <li>The in vitro/in vivo tested novel compounds are suitable for the treatment of pulmonary artery hypertension, fibrosis, cancer and bone diseases</li> </ul> <p><strong>IP Rights</strong><br> AEP application filed 02/2008<br> PCT application filed 02/2009<br> <br> <strong>Patent Owner</strong><br> Freie Universität Berlin.</p>

Further Information: PDF

ipal GmbH
Phone: +49 (0)30/2125-4820

Contact
Dr. Dirk Dantz

info@technologieallianz.de | TechnologieAllianz e.V.
Further information:
http://www.technologieallianz.de/angebote.php?sort=sag&id=2737&lang=en
http://www.technologieallianz.de

More articles from Technology Offerings:

nachricht New Lithium Salts of Pentafluorophenylamide Anions as Electrolytes in Lithium Ionic Batteries
18.04.2017 | TechnologieAllianz e.V.

nachricht Gratings on glass surfaces
28.03.2017 | TechnologieAllianz e.V.

All articles from Technology Offerings >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>